Home LiteratureArticle Details
PMID: 12063560 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.

International journal of oncology ·Vol. 21 ·No. 1 ·2002-07-00 ·Pages 135-44

Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH

Abstract

Cadherins play a crucial role in epithelial morphogenesis and mediate intercellular adhesion. These receptors bind catenins and are involved in signal transduction pathways that regulate cell growth and apoptosis, and are frequently down-regulated in invasive and metastatic carcinomas. In order to assess the role of E-cadherin in cell adhesion and growth, we transfected MCF-7 cells, a human breast cancer cell line, with a dominant-negative construct of E-cadherin (H-2kd-E-cad). The dominant-negative form of E-cadherin disrupted cell-cell adhesion of monolayer cells and induced an epithelial-to-fibroblastic conversion without any significant change in integrin profiles. Whereas control cells rapidly formed multicellular aggregates that tightly compacted into spheroids, dominant-negative transfected cells failed to compact and remained as loosely-associated cells. The transfectants exhibited down-regulation and redistribution of endogenous E-cadherin as well as increased levels of alpha- and beta-catenin. Importantly, the H-2kd-E-cad-transfected cells, when grown as multicellular aggregates, showed an increase in cell proliferation rate, compared to control cells. Overall, these observations suggest that in breast carcinoma, disruption of E-cadherin and catenin function modulates both cell-cell adhesion and permits escape from cell-cell contact-involved inhibition of cell growth.

MeSH Terms
Breast Neoplasms/metabolism,pathology Cadherins/physiology Cell Adhesion/physiology Cell Division Cell Movement Contact Inhibition/physiology Cytoskeletal Proteins/metabolism Down-Regulation Female Genes, Dominant H-2 Antigens/genetics,metabolism Humans Mutation Recombinant Fusion Proteins/metabolism Trans-Activators/metabolism Transfection Tumor Cells, Cultured Up-Regulation alpha Catenin beta Catenin
Chemicals
CTNNA1 protein, human CTNNB1 protein, human Cadherins Cytoskeletal Proteins H-2 Antigens H-2K(K) antigen Recombinant Fusion Proteins Trans-Activators alpha Catenin beta Catenin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Vizirianakis Ioannis S
Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, GR-54006 Thessaloniki, Greece. ivizir@pharm.auth.gr
Chen Yao-Qi
Kantak Seema S
Tsiftsoglou Asterios S
Kramer Randall H
Article Info
Journal
International journal of oncology
Abbr.
Int J Oncol
ISSN
1019-6439
Published
2002-07-00
Pages
135-44
Language
English
Region
Greece
NLM ID
9306042
Subset
IM
Grants
NCI NIH HHS · CA/DE11912 · United States
NIDCR NIH HHS · DE013904 · United States
NIDCR NIH HHS · DE11436 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com